Ocular Therapeutix announced changes to its executive team, with Pravin U. Dugel, MD, assuming the roles of president and CEO and Antony Mattessich stepping down from these positions, effective immediately.
Dugel will continue in his current roles of director and executive chairman, according to a press release.
“On behalf of the board of directors and employees of Ocular, I want to wholeheartedly express Ocular’s utmost gratitude for Antony's many years of exceptional service and unwavering commitment to the company,” Dugel said in the release. “His passion and